Cargando…
Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research
OBJECTIVES: Heterogeneity of results of exact same research experiments oppose a significant socioeconomic burden. Insufficient methodological reporting is likely to be one of the contributors to results heterogeneity; however, little knowledge on reporting habits of in vitro cancer research and the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171230/ https://www.ncbi.nlm.nih.gov/pubmed/35721833 http://dx.doi.org/10.1136/bmjos-2021-100272 |
_version_ | 1784721620290502656 |
---|---|
author | Sander, Timo Ghanawi, Joly Wilson, Emma Muhammad, Sajjad Macleod, Malcolm Kahlert, Ulf Dietrich |
author_facet | Sander, Timo Ghanawi, Joly Wilson, Emma Muhammad, Sajjad Macleod, Malcolm Kahlert, Ulf Dietrich |
author_sort | Sander, Timo |
collection | PubMed |
description | OBJECTIVES: Heterogeneity of results of exact same research experiments oppose a significant socioeconomic burden. Insufficient methodological reporting is likely to be one of the contributors to results heterogeneity; however, little knowledge on reporting habits of in vitro cancer research and their effects on results reproducibility is available. Exemplified by a commonly performed in vitro assay, we aim to fill this knowledge gap and to derive recommendations necessary for reproducible, robust and translational preclinical science. METHODS: Here, we use systematic review to describe reporting practices in in vitro glioblastoma research using the Uppsala-87 Malignant Glioma (U-87 MG) cell line and perform multilevel random-effects meta-analysis followed by meta-regression to explore sources of heterogeneity within that literature, and any associations between reporting characteristics and reported findings. Literature that includes experiments measuring the effect of temozolomide on the viability of U-87 MG cells is searched on three databases (Embase, PubMed and Web of Science). RESULTS: In 137 identified articles, the methodological reporting is incomplete, for example, medium glucose level and cell density are reported in only 21.2% and 16.8% of the articles. After adjustments for different drug concentrations and treatment durations, the results heterogeneity across the studies (I(2)=68.5%) is concerningly large. Differences in culture medium glucose level are a driver of this heterogeneity. However, infrequent reporting of most experimental parameters limits the analysis of reproducibility moderating parameters. CONCLUSIONS: Our results further support the ongoing efforts of establishing consensus reporting practices to elevate durability of results. By doing so, this work can raise awareness of how stricter reporting may help to improve the frequency of successful translation of preclinical results into human application. The authors received no specific funding for this work. A preregistered protocol is available at the Open Science Framework (https://osf.io/9k3dq). |
format | Online Article Text |
id | pubmed-9171230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-91712302022-06-16 Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research Sander, Timo Ghanawi, Joly Wilson, Emma Muhammad, Sajjad Macleod, Malcolm Kahlert, Ulf Dietrich BMJ Open Sci Original Research OBJECTIVES: Heterogeneity of results of exact same research experiments oppose a significant socioeconomic burden. Insufficient methodological reporting is likely to be one of the contributors to results heterogeneity; however, little knowledge on reporting habits of in vitro cancer research and their effects on results reproducibility is available. Exemplified by a commonly performed in vitro assay, we aim to fill this knowledge gap and to derive recommendations necessary for reproducible, robust and translational preclinical science. METHODS: Here, we use systematic review to describe reporting practices in in vitro glioblastoma research using the Uppsala-87 Malignant Glioma (U-87 MG) cell line and perform multilevel random-effects meta-analysis followed by meta-regression to explore sources of heterogeneity within that literature, and any associations between reporting characteristics and reported findings. Literature that includes experiments measuring the effect of temozolomide on the viability of U-87 MG cells is searched on three databases (Embase, PubMed and Web of Science). RESULTS: In 137 identified articles, the methodological reporting is incomplete, for example, medium glucose level and cell density are reported in only 21.2% and 16.8% of the articles. After adjustments for different drug concentrations and treatment durations, the results heterogeneity across the studies (I(2)=68.5%) is concerningly large. Differences in culture medium glucose level are a driver of this heterogeneity. However, infrequent reporting of most experimental parameters limits the analysis of reproducibility moderating parameters. CONCLUSIONS: Our results further support the ongoing efforts of establishing consensus reporting practices to elevate durability of results. By doing so, this work can raise awareness of how stricter reporting may help to improve the frequency of successful translation of preclinical results into human application. The authors received no specific funding for this work. A preregistered protocol is available at the Open Science Framework (https://osf.io/9k3dq). BMJ Publishing Group 2022-06-01 /pmc/articles/PMC9171230/ /pubmed/35721833 http://dx.doi.org/10.1136/bmjos-2021-100272 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Sander, Timo Ghanawi, Joly Wilson, Emma Muhammad, Sajjad Macleod, Malcolm Kahlert, Ulf Dietrich Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title | Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title_full | Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title_fullStr | Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title_full_unstemmed | Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title_short | Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
title_sort | meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171230/ https://www.ncbi.nlm.nih.gov/pubmed/35721833 http://dx.doi.org/10.1136/bmjos-2021-100272 |
work_keys_str_mv | AT sandertimo metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch AT ghanawijoly metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch AT wilsonemma metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch AT muhammadsajjad metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch AT macleodmalcolm metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch AT kahlertulfdietrich metaanalysisonreportingpracticesasasourceofheterogeneityininvitrocancerresearch |